Oric Pharmaceuticals's total assets for Q4 2025 were $411.00M, a decrease of -4.68% from the previous quarter. ORIC total liabilities were $26.64M for the fiscal quarter, a 9.75% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.